🔗 Share this article

A shadow economy for unapproved slimming medications is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Experimental Drug Acquiring Traction Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Followers are urged to contact these accounts directly for source information, while also obtaining discount codes.

Thriving Trade on Messaging Platforms

Separately, a robust trade exists on messaging services, where communities with numerous of members share “before and after” images, administration instructions and assertions of next-day British shipping. Sellers promote the drug there before directing buyers to WhatsApp for transactions.

Learning About The Experimental Drug

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and glucagon. Early trials indicate it could help individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Healthcare Experts Express Worries

However, physicians and chemists have warned that the sale of what is still an unapproved drug in the UK is worrisome and could lead to users administering substances of unknown origin.

Several experts said the demand for retatrutide could be linked to the rising price of approved weight loss products such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unlicensed drug that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several influencers try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still violate pharmaceutical, advertising, and consumer laws, risking penalties, legal action or prison.

Service Response and Content Elimination

According to TikTok, the service has taken down violative content and banned related keywords and query recommendations. The company said it was committed to maintaining the platform safe and allocating resources in strengthening compliance measures.

Digital Trading Activities

Investigations also found groups with up to nine thousand participants selling retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately brings up channels with numerous of users, filled with photos of slimming results, glowing reviews and step-by-step instructions for preparing or administering at home.

Within minutes of entering one group, a seller posted WhatsApp details, where most transactions take place. The vendor sent an guidebook and guaranteed shipping within 48 hours. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one asked about body mass, health issues or past usage.

Item Information and Pricing

Within these communities, posts display dark colored parcels with Royal Mail stickers, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at residence with purified liquid, or ready-to-use injectors typically priced at £160 for 20mg. When asked how much time a injector should last, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A representative for the messaging service stated it regularly moderated harmful content on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are injecting substances they can’t verify. Even if the research behind retatrutide is sound, these digital products may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor connected the surge in interest to recent price rises for approved slimming drugs such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit injections are highly risky. You cannot know what’s contained or whether the conditions they were made in was sterile,” she explained.

Her staff has previously encountered patients injured by self-injection from unconfirmed sources. “We understand the disappointment, but buying from Telegram or WhatsApp is gambling with your well-being,” stated Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly said the substance was in third stage research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this point no one can market [it] for human use,” they explained, adding that any product “falsely representing itself as a company investigational substance not yet approved … may expose patients to possibly serious health risks”.